Buffalo Translational Consortium News
Noted Michigan State University Immunodermatologist Animesh Sinha recruited to become Chair of Dermatology at UB and Roswell Park
Following a comprehensive national search jointly conducted by the UB School of Medicine and Biomedical Sciences and Roswell Park Cancer Institute, Animesh Sinha, MD, PhD, has been appointed as the inaugural Rita M. and Ralph T. Behling, MD, Professor and Chair of the Department of Dermatology. As a physician scientist, Dr. Sinha will bring a robust translational research program in the fields of immunological tolerance and autoimmunity which will complement several existing basic and translational research programs in the Buffalo Translational Consortium. This appointment will be effective in April 2011.
Previously separate departments, the UB and Roswell Park Departments of Dermatology were unified 10 years ago into a department that spans both institutions. In addition to stimulating academic partnerships, this arrangement facilitates the growth of a comprehensive clinical program based at Roswell Park, UBMD (the School of Medicine practice plan), Great Lakes Health and the community. Dr. Sinha brings broad vision and experience to build and expand this department that has a long and rich history.
A native of Canada, Dr. Sinha received his MD and PhD with a concentration in immunology from the University of Alberta in Edmonton, followed by a 5-year research fellowship in immunology at Stanford University in California. He completed his residency in dermatology at the University of Alberta (1992-95) and at Yale University (1995-98) in New Haven, Connecticut. He joined the faculty of Weill-Cornell Medical College in New York City in 1998 and served as Director of the Residency Training Program. In 2005, he was recruited to Michigan State University as Chief of the Division of Dermatology and Cutaneous Sciences, and Director of the Center for Investigative Dermatology.
As a physician-scientist, Dr. Sinha’s long-term research interests lie in the broad area of immunodermatology. He has received multiple grants to investigate the genetic mechanisms underlying the autoimmune diseases alopecia, lupus, psoriasis, pemphigus, a rare group of blistering autoimmune diseases that affect the skin and mucous membranes, and vitiglio, a chronic disorder that causes depigmentation of patches of skin. Dr. Sinha’s translational and clinical research programs have been consistently supported since 1998 with grants from the National Institutes of Health and research foundations.
Dr. Sinha currently is pursuing two major lines of investigation, concentrating on the inductive and regulatory events of the autoimmune pathway, with the goal of pinpointing targets for immune intervention and developing potential gene therapies for autoimmune diseases. The work has resulted in 87 papers published or in press, and has garnered Sinha numerous awards, including the 2009 Doctor of the Year/Excellence in Research Award from the International Pemphigus and Pemphoid Foundation. He has lectured nationally and internationally, serves on peer-review study sections of the National Institutes of Health, the Arthritis Foundation and Alliance for Lupus Research, and is a member of the Medical/Scientific Advisory Boards of the International Pemphigus and Pemphigoid Foundation, American Vitiligo Research Foundation, and Foundation for Global Skin Health Strategies.
Dr. Nathalie Zeitouni of Roswell Park served as the interim Chair of the Department of Dermatology for the past 2 years following the death of Dr. Allan Oseroff. The Search Committee was co-chaired by Drs. David Hohn and Timothy Murphy and included Drs. Richard Cheney, Roberto Pili, John Kane, Sandra Golnick, Stanley Schwartz, Craig Miller and Chester Fox and the invaluable assistance of Dianne Wolff, Kathryn Hall and Nancy Glieco.
UB is awarded $8.2 million NIH grant for Women’s Health Initiative Regional Coordinating Center directed by Dr. Jean Wactawski-Wende
UB has received an $8.2 million award from the National Heart, Lung and Blood Institute to administer a new round of studies that extend the Women's Health Initiative (WHI) research for another five years. The initial 40 WHI centers across the U.S. have been grouped into four regional centers to carry out this new initiative. UB will oversee scientific direction and the participant contacts of the Northeast region's nine institutions. Jean Wactawski-Wende, PhD Professor and Associate Chair of Social and Preventive Medicine in the School of Public Health and Health and Health Professions is principal investigator on the new award. Dr. Wactawski-Wende is Co Director of the Buffalo CTRC Clinical Research Center.
UB HIV Clinical Pharmacology Research Program receives $2.3 million NIH training grant directed by Dr. Gene Morse
The NIH has awarded $2.3 million to the UB HIV Clinical Pharmacology Research Program housed in the UB School of Pharmacy and Pharmaceutical Sciences and Center of Excellence in Bioinformatics and Life Sciences to host visiting pharmaceutical scientists from resource limited African countries to train them in conducting clinical trials and research on HIV/AIDS. The HIV Clinical Pharmacology Research Program has received more that $11 million in NIH funding since 2008. The program includes a Pharmacology Quality Assurance (CPQA) program, designed to ensure that HIV/AIDS researchers in resource-limited countries conducted high-quality, pharmacology-focused clinical trials. Gene Morse PharmD, Professor of Pharmacy Practice and Associate Director of the Center for Excellence in Bioinformatics and Life Sciences is principal investigator. Dr. Morse is also Associate Director of the Institute for Healthcare Informatics and plays a leadership role in the Biomedical Informatics Key Function.
Read more: http://www.buffalo.edu/news/11975
HEALTHeLINK awarded $10 Million Health Information Technology Grant from New York State Department of Health
HEALTHeLINK is a BTC community partner institution and the Western New York Clinical Information Exchange that includes clinical data from all 3 BTC healthcare institutions (Great Lakes Health, Roswell Park Cancer Institute and UBMD). HEALTHeLINK has been awarded a $10 million grant from New York State to improve the coordination of health care through the use of health information technology. The grant will support the creation of a clinical information model to enhance population and public health services. HEALTHeLINK participated in the initial design and testing of the public health information exchange model being used across New York State and is thus well positioned to further develop the model to track, monitor, and report on public health information in Western New York. These systems will then be replicated by other regional health information organizations (RHIOs) across the state.
Read more about it on WNY Healthelink.com: http://www.wnyhealthelink.com/
And on BuffaloNews.com: http://www.buffalonews.com/